CN103356697A - Stem cell preparation and oral fluid prepared therefrom - Google Patents
Stem cell preparation and oral fluid prepared therefrom Download PDFInfo
- Publication number
- CN103356697A CN103356697A CN2012100854258A CN201210085425A CN103356697A CN 103356697 A CN103356697 A CN 103356697A CN 2012100854258 A CN2012100854258 A CN 2012100854258A CN 201210085425 A CN201210085425 A CN 201210085425A CN 103356697 A CN103356697 A CN 103356697A
- Authority
- CN
- China
- Prior art keywords
- stem cell
- cell preparation
- medicine
- stone
- cell medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to the field of medicaments and relates to a stem cell preparation and an oral fluid prepared therefrom. The stem cell preparation is prepared from the following raw materials in weight percentage according to the following technical steps: mixing and crushing 20% of medical stone, 10% of stone needle, 10% of green frontiers stone, 10% of tinospora root radix tinosporae, 10% of talc, 10% of stalactite, 20% of marmor serpentinatum and 10% of red halloysite to nanometer particles so as to obtain mixed stone powder; and then sterilizing the mixed stone powder to obtain the stem cell preparation. The stem cell oral fluid is prepared after adding auxiliary materials into the stem cell preparation. The stem cell preparation disclosed by the invention causes no toxic and side effects, is good for health of human body, and replenishes mineral substances and a plurality of trace elements, so the stem cell preparation is a substitute product following antibiotic and hormone medicaments.
Description
Technical field
The invention belongs to drug world, relate to the oral liquid of a kind of stem cell medicine and preparation thereof.
Background technology
Since the bright antibiotics of human spontaneous, antibiotics has become the important drugs for the treatment of disease.But abuse of antibiotics not only makes medicine lose original effect, but also can cause great harm to human body.Spread unchecked along with antibiotic at present, human body has produced drug resistance, and antibiotic is also helpless in face of numerous disease.The hormone that in succession produced afterwards besides although disease is had certain curative effect and control action, has serious killing and wounding and destructive power to cell.In the face of thousands of kinds of diseases, the mankind are starved of a kind of medicine multi-functional, nontoxic, that have no side effect and occur.
Summary of the invention
Technical problem to be solved by this invention provides the oral liquid of a kind of stem cell medicine and preparation thereof, not only replenishes human body various trace elements and mineral, and prevention and treatment various diseases, useful health.
Described stem cell medicine, raw material by following percetage by weight is made according to following processing step: with Maifanitum 20%, stone needle 10%, Lapis Chloriti 10%, Lapis Micae Aureus 10%, Talcum 10%, Stalactitum 10%, Ophicalcitum 20%, Halloysitum Rubrum 10% co-grinding to nanometer particle, obtain mixing stone powder, make stem cell medicine through sterilization.
The fineness of described mixing stone powder is 10~20nm.
The stem cell oral liquid of described stem cell medicine preparation, made according to following processing step by the raw material of following percetage by weight:
(1) stem cell medicine 30% and pure water 70% are joined in the reactor container, boiled again when boiling 10~30 minutes, then poured rustless steel purification tank cooling and purifying into 15~20 days, the supernatant is taken out;
(2) press following weight ratio obtain solution in container: the supernatant 90%, vinegar 5%, glucose 5% behind the solution mix homogeneously for preparing, obtain the stem cell oral liquid through sterilization again.
The present invention can make pharmaceutically acceptable various preparation, such as capsule, oral liquid, tablet, injection etc.Sterilization process is common process pharmaceutically.
The present invention possesses following characteristics:
1, can repair aging cell, the disorderly cell of adjustment of cell, activation of corrupted;
2, can strengthen Normocellular vigor;
3, nontoxic, have no side effect, oral administration and externally is the material that cell is depended on for existence; Carrier and the basic substance of Growth of Cells;
4, virus there is resistancing action, virus is run its course.
The stem cell gene therapy is thought: all diseases all be gene and cell impaired due to, human diseases only has two kinds, i.e. endopathy and exopathia, example: cancer, psychosis, psoriasis, Peptic Ulcers, heart disease etc. belong to endopathy.Example: acquired immune deficiency syndrome (AIDS), diabetes, flu, uremia, painful wind, arthritis, alimentary toxicosis, alcoholism, chemical poisoning, drug intoxication etc. belong to exopathia.The medicine that uses also only has two kinds, be toxic medicament and nontoxic medicine, nontoxic medicine was exactly " the stem cell new drug " of the present invention's development, through the clinical use in more than 10 years, facts have proved fully to replace a large amount of toxic medicament, chemical drugs, can replace antibiotics and hormone medicine.
Stem cell is the money material of cell, is again the food of cell, uses the stem cell product just to equal cell and injects " fund ".
The present invention carries out clinical experiment to 360 routine patients.The inventor is divided into all diseases: endopathy and exopathia two large classes.The pathogenic factor of endopathy is relevant with seven emotions, that is: happiness, anger, melancholy, think of, compassion, probably,, frightened; Exopathia is relevant with six climate exopathogens, that is: wind, heat, dry, wet, cold, fiery; Requirement is all filled in the treatment registration form, the endogenous cause of ill case before using: cancer, heart disease, cerebroma, psoriasis, gastric ulcer, duodenal ulcer etc.Exopathogenic factor case: Common Cold, rheumatic arthritis, cervical vertebra, scapulohumeral periarthritis, burn and scald, abscess, dermatosis, alimentary toxicosis, diabetes, uremia etc.Endopathy is tried out 180 examples, and exopathia is tried out 180 examples.
1, utilize the present invention to the clinical trial of endopathy:
Clinical in the 180 routine endopathies, wherein cancer is 60, accounts for 33.3% of endopathy, clinical observation: can keep taking stem cell oral liquid 500ml every day, allly adhere to that user of the present invention all can delay life, check result after February: normal, check transference cure after March, curative effect determinate standard is cured clinical symptom disappearance, functional activity is all normal, the physico-chemical examination result is normal, effectively, can work and work.Model case: pay XX, suffered from pulmonary carcinoma in 2000 and shifted gastric cancer, can't carry out because large tracts of land shifts operation, take the present invention's rehabilitation in 60 days, disappear to the examination in hospital cancer.It is still healthy now to have spent 14 years.8 routine cancer patients are wherein arranged because not adhering to taking death after March.Effective percentage 98%, cure rate 86.7%.
Psoriasis 32 people account for 17.8% of endopathy.Clinical observation: every day, stem cell oral liquid 500ml was taken in maintenance, simultaneously stem cell medicine was applied in the affected part, wherein had 4 people not heal every day three times, effective percentage 98%, cure rate 87.5%.Model case: Lee XX, suffered from psoriasis in 2000, take 500ml of the present invention every day, simultaneously stem cell medicine is applied in the affected part, to treat altogether 3 months every day three times, it is normal that the examination in hospital indices recovers.Follow up a case by regular visits to after 8 years still healthy.
Heart disease 22 people account for 12.2% of endopathy, clinical observation: every day, stem cell oral liquid 300ml was taken in maintenance, treated effective percentage 98%, cure rate 90% 2 months.Model case: Cao XX, suffer from a heart complaint, cardiovascular is expanded automatically, and it is normal that heart rate recovers, heart beating, nervous phenomenon disappears automatically, and symptomatology disappears, and can participate in normal work and work.
Difficult miscellaneous diseases example in the endopathy: septicemia, rheumatoid, central neurocytoma, lupus erythematosus.This therapy all is called endopathy.Can't operative treatment in these diseases of hospital, user 66 people, clinical trial: oral stem cell oral liquid of the present invention every day three times, each 100ml, 28 days is a course for the treatment of.Wherein lupus erythematosus two people are dead, and all the other all recover normal.Effective percentage 97%, cure rate 93.9%.Curative effect determinate standard: cure, clinical symptom disappearance, it is normal that functional activity recovers, and the physico-chemical examination result is normal, and effectively, symptomatology disappears, or cardinal symptom is eliminated.Various functions are recovered normally substantially, can participate in normal work and work.Invalid: lupus erythematosus 2 examples are dead, do not have successful rescue.
2, utilize the present invention to the exopathia clinical trial:
Clinical data 180 exception due to illness, male 90 examples, women 90 examples, the age one-year-old~do not wait in 80 years old, wherein: Common Cold, rheumatic arthritis 80 examples account for exopathic 44.4%.
Therapeutic Method: oral stem cell oral liquid of the present invention every day three times, each 100ml generally disappears one to three day Common Cold, and rheumatic arthritis was cured in 7~10 days.Criterion: cure, clinical symptom disappearance, functional activity is all normal, and the physico-chemical examination result is normal; Effectively, symptomatology disappears, or the cardinal symptom elimination, and function of joint is recovered normally substantially, can participate in normal work and work.2 examples are invalid: front without significant change with treatment.
Wherein burn and scald, various dermatosis are tested 60 examples, account for exopathia 33.3%.Therapeutic Method: directly stem cell medicine is applied in the affected part, generally cure the treatment standard determination every day three times within a week: cure clinical symptom disappearance or cardinal symptom and disappear, the physico-chemical examination result is normal; Effectively: symptomatology is eliminated, and skin affected part function is recovered normally to take part in the work and work substantially.The result cures 60 examples, total effective rate 100%, and wherein the longest 20 days of the course for the treatment of in 60 examples, the shortest 2 days, the treatment natural law was about 10 days.
40 Cases of Diabetes Mellitus accounts for exopathia 22.2%.Clinical observation: keep taking stem cell oral liquid 500ml every day.Wherein there are 2 people not heal, cure rate 95%, model case: an XX, calendar year 2001 is suffered from diabetes, takes 500ml of the present invention every day, takes altogether three months, and it is normal that the examination in hospital indices recovers.Follow up a case by regular visits to after 9 years healthy.
The present invention has following beneficial effect:
Cost of the present invention is low, quality is high, effective, benefit is large, the scope of application is extensive, non-environmental-pollution.As long as lived animal and plant, human body all can use, have no side effect, be the generation substitute products behind antibiotic and hormone medicine.The present invention replenishes mineral and various trace elements to the human body beneficial.
The specific embodiment
Below in conjunction with embodiment the present invention is described further.
Embodiment 1
Described stem cell medicine, made according to following processing step by the raw material of following percetage by weight:
With Maifanitum 20%, stone needle 10%, Lapis Chloriti 10%, Lapis Micae Aureus 10%, Talcum 10%, Stalactitum 10%, Ophicalcitum 20%, Halloysitum Rubrum 10% co-grinding to nanometer particle, obtain mixing stone powder, make stem cell medicine through sterilization, can directly be applied in the affected part.
The fineness of described mixing stone powder is 20nm.
Embodiment 2
The stem cell medicine that obtains among the embodiment 1 is prepared the stem cell oral liquid, makes according to raw material and the step of following percetage by weight:
(1) stem cell medicine 30% and pure water 70% are joined in the reactor container, boiled again when boiling 15 minutes, then poured rustless steel purification tank cooling and purifying into 15 days, the supernatant is taken out;
(2) press following weight ratio obtain solution in container: the supernatant 90%, vinegar 5%, glucose 5% behind the solution mix homogeneously for preparing, obtain the stem cell oral liquid through sterilization again.
Claims (3)
1. stem cell medicine is characterized in that being made according to following processing step by the raw material of following percetage by weight:
Maifanitum 20%, stone needle 10%, Lapis Chloriti 10%, Lapis Micae Aureus 10%, Talcum 10%, Stalactitum 10%, Ophicalcitum 20%, Halloysitum Rubrum 10% co-grinding to nanometer particle, are obtained mixing stone powder, make stem cell medicine through sterilization.
2. stem cell medicine according to claim 1, the fineness that it is characterized in that described mixing stone powder is 10~20nm.
3. the stem cell oral liquid of a stem cell medicine claimed in claim 1 preparation is characterized in that being made according to following processing step by the raw material of following percetage by weight:
(1) stem cell medicine 30% and pure water 70% are joined in the reactor container, boiled again when boiling 10~30 minutes, then poured rustless steel purification tank cooling and purifying into 15~20 days, the supernatant is taken out;
(2) press following weight ratio obtain solution in container: the supernatant 90%, vinegar 5%, glucose 5% behind the solution mix homogeneously for preparing, obtain the stem cell oral liquid through sterilization again.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210085425.8A CN103356697B (en) | 2012-03-28 | 2012-03-28 | The oral liquid of a kind of stem cell medicine and preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210085425.8A CN103356697B (en) | 2012-03-28 | 2012-03-28 | The oral liquid of a kind of stem cell medicine and preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103356697A true CN103356697A (en) | 2013-10-23 |
CN103356697B CN103356697B (en) | 2015-08-12 |
Family
ID=49359511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210085425.8A Active CN103356697B (en) | 2012-03-28 | 2012-03-28 | The oral liquid of a kind of stem cell medicine and preparation thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103356697B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105687343A (en) * | 2016-03-18 | 2016-06-22 | 张岩 | Traditional Chinese medicine composition for treating psoriasis |
CN107801917A (en) * | 2017-10-25 | 2018-03-16 | 闫荣平 | A kind of maize straw albumen powder and preparation method thereof |
CN107998148A (en) * | 2017-10-25 | 2018-05-08 | 闫荣平 | A kind of stem cell factor powder, its preparation method and its oral liquid of preparation |
CN109078159A (en) * | 2018-09-04 | 2018-12-25 | 汪阳军 | It is a kind of for treating the cell nutritious element and production method of dry eyes |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101301072A (en) * | 2008-06-22 | 2008-11-12 | 闫荣平 | Cell food capable of enhancing vigor of gene |
CN102018593A (en) * | 2009-09-23 | 2011-04-20 | 赵文忠 | Healing stone pillow for treating cervical spondylosis |
-
2012
- 2012-03-28 CN CN201210085425.8A patent/CN103356697B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101301072A (en) * | 2008-06-22 | 2008-11-12 | 闫荣平 | Cell food capable of enhancing vigor of gene |
CN102018593A (en) * | 2009-09-23 | 2011-04-20 | 赵文忠 | Healing stone pillow for treating cervical spondylosis |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105687343A (en) * | 2016-03-18 | 2016-06-22 | 张岩 | Traditional Chinese medicine composition for treating psoriasis |
CN107801917A (en) * | 2017-10-25 | 2018-03-16 | 闫荣平 | A kind of maize straw albumen powder and preparation method thereof |
CN107998148A (en) * | 2017-10-25 | 2018-05-08 | 闫荣平 | A kind of stem cell factor powder, its preparation method and its oral liquid of preparation |
CN109078159A (en) * | 2018-09-04 | 2018-12-25 | 汪阳军 | It is a kind of for treating the cell nutritious element and production method of dry eyes |
Also Published As
Publication number | Publication date |
---|---|
CN103356697B (en) | 2015-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102988772B (en) | TCM (Traditional Chinese medicine) composition for treating infantile acute infantile convulsions and preparation method thereof | |
CN102258671B (en) | Plaster for treating gout and preparation method thereof | |
CN103356697B (en) | The oral liquid of a kind of stem cell medicine and preparation thereof | |
CN101810642B (en) | Chinese medicinal preparation for treating canker sores and acute tonsillitis and preparation method thereof | |
CN105232976A (en) | Composition for preventing and/or treating sub-health | |
CN102552361A (en) | Externally applied medicinal liquor and preparation method thereof | |
CN101904998B (en) | Special medicament for treating dermatophytosis and preparation method thereof | |
CN104623416B (en) | A kind of traditional Chinese medicine health care preparation for being used to recuperate under medical treatment amnesia | |
CN102579568B (en) | Pure traditional Chinese medicine composition for treating various hemorrhage diseases and preparation method of same | |
CN103083488B (en) | Traditional Chinese medical composition for treating bone disease as well as preparation thereof | |
CN1935157B (en) | Medical stone emulsifiable paste for treating skin disease and its preparing method | |
CN110772627B (en) | Tibetan medicine rheumatism eliminating ointment and preparation method and application thereof | |
CN104547851B (en) | One treats hypertensive medicine | |
CN102146334A (en) | Donkey-hide gelatin wine | |
CN102716448A (en) | Chinese patent medicine and TCM decoction capable of effectively curing nausea and vomiting | |
CN102579617A (en) | Traditional Chinese medicine capsule for treating chronic neck, shoulder, waist and leg pains and processing method of same | |
CN102671076B (en) | Medicament for treating gout | |
CN101843846A (en) | Chinese medicinal ointment for treating skin diseases | |
CN100571722C (en) | Treatment is suffered from a deficiency of the kidney and the pharmaceutical composition of climacteric syndrome and preparation method thereof | |
CN101264197A (en) | Medicine for treating sciatica | |
CN102743574B (en) | Compound Chinese herbal medicine capsule for treating and killing mycobacterium tuberculosis and preparation method | |
CN101474280B (en) | Medicament for treating burn and scald, and preparation method thereof | |
CN104208511A (en) | Yao medicine composition capable of strengthening stomach and removing dampness and preparation method thereof | |
CN102091235B (en) | Medicament for treating vertebara swell and production method thereof | |
CN103751235A (en) | Traditional Chinese medicine composition for treating dysentery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20131023 Assignee: Ningxia Mel Biotechnology Co. Ltd. Assignor: Yan Bin Contract record no.: 2017990000102 Denomination of invention: Stem cell preparation and oral fluid prepared therefrom Granted publication date: 20150812 License type: Common License Record date: 20170327 |
|
EE01 | Entry into force of recordation of patent licensing contract |